The role of folate receptor α in cancer development, progression and treatment: cause, consequence or innocent bystander?
LE Kelemen - International journal of cancer, 2006 - Wiley Online Library
Folate receptor α (FRα) is a membrane‐bound protein with high affinity for binding and
transporting physiologic levels of folate into cells. Folate is a basic component of cell …
transporting physiologic levels of folate into cells. Folate is a basic component of cell …
[HTML][HTML] Folate receptor as a biomarker and therapeutic target in solid tumors
Folate is a B vitamin necessary for basic biological functions, including rapid cell turnover
occurring in cancer cell proliferation. Though the role of folate as a causative versus …
occurring in cancer cell proliferation. Though the role of folate as a causative versus …
[PDF][PDF] Role of folate receptor genes in reproduction and related cancers
H Elnakat, M Ratnam - Front Biosci, 2006 - article.imrpress.com
Introduction 3. Expression of FR in normal reproductive tissues 4. Role of FR during
pregnancy and lactation 4.1. Trans-placental folate uptake 4.2. Embryonal development 4.3 …
pregnancy and lactation 4.1. Trans-placental folate uptake 4.2. Embryonal development 4.3 …
Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers
S Notaro, D Reimer, H Fiegl, G Schmid, A Wiedemair… - BMC cancer, 2016 - Springer
Background In this retrospective study we evaluated the respective correlations and clinical
relevance of FOLR1 mRNA expression, FOLR1 promoter specific methylation and global …
relevance of FOLR1 mRNA expression, FOLR1 promoter specific methylation and global …
The role of α-folate receptor-mediated transport in the antitumor activity of antifolate drugs
DS Theti, AL Jackman - Clinical cancer research, 2004 - AACR
Abstract Purpose: Raltitrexed, pemetrexed, lometrexol, and ZD9331 are antifolate drugs
transported into cells via the ubiquitously expressed reduced-folate carrier. They display …
transported into cells via the ubiquitously expressed reduced-folate carrier. They display …
Activation of KLF8 transcription by focal adhesion kinase in human ovarian epithelial and cancer cells
X Wang, AM Urvalek, J Liu, J Zhao - Journal of Biological Chemistry, 2008 - ASBMB
KLF8 (Krüppel-like factor 8) is a transcription factor downstream of focal adhesion kinase
(FAK) important in the regulation of the cell cycle and also plays a critical role in oncogenic …
(FAK) important in the regulation of the cell cycle and also plays a critical role in oncogenic …
A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer
I Vergote, H Calvert, M Kania, C Kaiser… - European Journal of …, 2009 - Elsevier
PURPOSE: We conducted a randomised phase II study to assess the safety and efficacy of
standard versus high-dose pemetrexed in platinum-resistant epithelial ovarian cancer (PR …
standard versus high-dose pemetrexed in platinum-resistant epithelial ovarian cancer (PR …
Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells
E Sanna, S Miotti, M Mazzi, G De Santis… - Experimental cell …, 2007 - Elsevier
Caveolin-1 (cav-1), a member of a protein family associated mainly with cell membrane
microdomains in many cell types, acts as a tumor suppressor in ovarian carcinoma cells …
microdomains in many cell types, acts as a tumor suppressor in ovarian carcinoma cells …
Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer
We recently identified HSulf-1 as a down-regulated gene in ovarian carcinomas. Our
previous analysis indicated that HSulf-1 inactivation in ovarian cancers is partly mediated by …
previous analysis indicated that HSulf-1 inactivation in ovarian cancers is partly mediated by …
Folate receptor targeted liposomes encapsulating anti-cancer drugs
Among all available lipid based nanoparticulate systems, the success of liposomal drug
delivery system is evident by the number of liposomal products available in the market or …
delivery system is evident by the number of liposomal products available in the market or …